ID: ALA3219985

Max Phase: Preclinical

Molecular Formula: C12H20O2S

Molecular Weight: 228.36

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)=CCC/C(C)=C/CSCC(=O)O

Standard InChI:  InChI=1S/C12H20O2S/c1-10(2)5-4-6-11(3)7-8-15-9-12(13)14/h5,7H,4,6,8-9H2,1-3H3,(H,13,14)/b11-7+

Standard InChI Key:  LVQFBSCMGBXDGN-YRNVUSSQSA-N

Associated Targets(Human)

Isoprenylcysteine carboxyl methyltransferase 596 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 228.36Molecular Weight (Monoisotopic): 228.1184AlogP: 3.50#Rotatable Bonds: 7
Polar Surface Area: 37.30Molecular Species: ACIDHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 4.61CX Basic pKa: CX LogP: 3.31CX LogD: 0.59
Aromatic Rings: 0Heavy Atoms: 15QED Weighted: 0.54Np Likeness Score: 1.17

References

1. Majmudar JD, Morrison-Logue A, Song J, Hrycyna CA, Gibbs RA.  (2012)  Identification of a novel nanomolar inhibitor of hIcmt via a carboxylate replacement approach,  (9): [10.1039/C2MD20108A]

Source